CRISPR-Cas systems: ushering in the new genome editing era

Bioengineered. 2018;9(1):214-221. doi: 10.1080/21655979.2018.1470720.

Abstract

In recent years there has been great progress with the implementation and utilization of Clustered Regularly Interspaced Palindromic Repeats (CRISPR) and CRISPR-associated protein (Cas) systems in the world of genetic engineering. Many forms of CRISPR-Cas9 have been developed as genome editing tools and techniques and, most recently, several non-genome editing CRISPR-Cas systems have emerged. Most of the CRISPR-Cas systems have been classified as either Class I or Class II and are further divided among several subtypes within each class. Research teams and companies are currently in dispute over patents for these CRISPR-Cas systems as numerous powerful applications are concurrently under development. This mini review summarizes the appearance of CRISPR-Cas systems with a focus on the predominant CRISPR-Cas9 system as well as the classifications and subtypes for CRISPR-Cas. Non-genome editing uses of CRISPR-Cas are also highlighted and a brief overview of the commercialization of CRISPR is provided.

Keywords: CRISPR products; CRISPR-Cas figure; Cas classes; Cas types; Cas13; Cas9; HDR; NHEJ; TALEN; ZFN; genome editing.

Publication types

  • Review

MeSH terms

  • Animals
  • Animals, Genetically Modified
  • CRISPR-Associated Protein 9 / genetics*
  • CRISPR-Associated Protein 9 / metabolism
  • CRISPR-Cas Systems*
  • Clustered Regularly Interspaced Short Palindromic Repeats*
  • DNA / genetics
  • DNA / metabolism
  • DNA End-Joining Repair
  • Gene Editing / methods*
  • Genome*
  • Humans
  • Patents as Topic
  • Plants / genetics
  • Plants, Genetically Modified
  • RNA, Guide, CRISPR-Cas Systems / genetics*
  • RNA, Guide, CRISPR-Cas Systems / metabolism
  • Transcription Activator-Like Effector Nucleases / genetics
  • Transcription Activator-Like Effector Nucleases / metabolism

Substances

  • RNA, Guide, CRISPR-Cas Systems
  • DNA
  • CRISPR-Associated Protein 9
  • Transcription Activator-Like Effector Nucleases